1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Liver Cancer Diagnostics Market – By Type

1.3.2        North America Liver Cancer Diagnostics Market – By End User

1.3.3        North America Liver Cancer Diagnostics Market – By Country

2.           North America Liver Cancer Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Liver Cancer Diagnostics Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           North America Liver Cancer Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Liver Cancer

5.1.2        Strengthening R&D Investments for the Development of Novel Diagnostic Testing

5.2         Market Restraints

5.2.1        Higher Cost of Technologically Advanced Liver Cancer Diagnostic Solutions

5.3         Market Opportunities

5.3.1        Heighten Demand for Point-of-Care Testing

5.4         Future Trends

5.4.1        Prospering Emergence of New Technologies

5.5         Impact Analysis

6.           North America Liver Cancer Diagnostics Market Analysis

6.1         North America Liver Cancer Diagnostics Market Revenue Forecast and Analysis

7.           North America Liver Cancer Diagnostics Market Analysis – By Type

7.1         Overview

7.2         North America Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)

7.3         Laboratory Tests

7.3.1        Overview

7.3.2        Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Blood Tests

7.3.2.1.1          Overview

7.3.2.1.2          Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Biomarkers

7.3.2.2.1          Overview

7.3.2.2.2          Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Endoscopy

7.4.1        Overview

7.4.2        Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Imaging

7.5.1        Overview

7.5.2        Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Biopsy

7.6.1        Overview

7.6.2        Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Liver Cancer Diagnostics Market Analysis – By End User

8.1         Overview

8.2         North America Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)

8.3         Hospitals and Diagnostics Laboratories

8.3.1        Overview

8.3.2        Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Academic and Research Institutes

8.4.1        Overview

8.4.2        Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         CRO Laboratories

8.5.1        Overview

8.5.2        CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Liver Cancer Diagnostics Market – Country Analysis

9.1         Overview

9.1.1        North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

9.1.1.1          US: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1          Overview

9.1.1.1.2          US: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3          US Liver Cancer Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3.1        US Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.4          US Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

9.1.1.2          Canada: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.1          Overview

9.1.1.2.2          Canada: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3          Canada Liver Cancer Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3.1        Canada Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.4          Canada Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

9.1.1.3          Mexico: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1          Overview

9.1.1.3.2          Mexico: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3          Mexico Liver Cancer Diagnostics Market, by Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3.1        Mexico Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.4          Mexico Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.        North America Liver Cancer Diagnostics Market– Industry Landscape

10.1      Overview

10.2      Organic Developments

10.2.1     Overview

10.3      Inorganic Developments

10.3.1     Overview

11.        Company Profiles

11.1      Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      bioMerieux SA

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      F. HOFFMANN-LA ROCHE LTD.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Illumina, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Koninklijke Philips N.V.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      QIAGEN

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Siemens Healthineers AG

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      THERMO FISHER SCIENTIFIC INC.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      GE Healthcare

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Perspectum

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Products and Services

11.10.4  Financial Overview

11.10.5  SWOT Analysis

11.10.6  Key Developments

11.11   Helio, Inc

11.11.1  Key Facts

11.11.2  Business Description

11.11.3  Products and Services

11.11.4  Financial Overview

11.11.5  SWOT Analysis

11.11.6  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Liver Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             US Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

Table 3.             US Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 4.             Canada Liver Cancer Diagnostics Market, by Type-Revenue and Forecast to 2028 (USD Million)

Table 5.             Canada Liver Cancer Diagnostics Market, by Laboratory Tests – Revenue and Forecast to 2028 (USD Million)

Table 6.             Canada Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 7.             Mexico Liver Cancer Diagnostics Market, by Type -Revenue and Forecast to 2028 (USD Million)

Table 8.             Mexico Liver Cancer Diagnostics Market, by Laboratory Tests -Revenue and Forecast to 2028 (USD Million)

Table 9.             Mexico Liver Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 10.          Organic Developments in the Liver Cancer Diagnostics Market

Table 11.          Inorganic Developments in the Liver Cancer Diagnostics Market

Table 12.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Liver Cancer Diagnostics Market Segmentation

Figure 2.           North America Liver Cancer Diagnostics Market Segmentation, By Country

Figure 3.           North America Liver Cancer Diagnostics Market Overview

Figure 4.           Laboratory Tests Segment Held Largest Share by Type in North America Liver Cancer Diagnostics Market

Figure 5.           The US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America Liver Cancer Diagnostics Market, Industry Landscape

Figure 7.           North America: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           Impact Analysis of Drivers and Restraint Pertaining to North America Liver Cancer Diagnostics Market

Figure 10.        North America Liver Cancer Diagnostics Market – Revenue Forecast and Analysis – 2021- 2028

Figure 11.        North America Liver Cancer Diagnostics Market Revenue Share, by Type (2021 and 2028)

Figure 12.        Laboratory Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Blood Tests: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Biomarkers: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Endoscopy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Imaging: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Biopsy: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Others: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Liver Cancer Diagnostics Market Revenue Share, By End User (2021 and 2028)

Figure 20.        Hospitals and Diagnostics Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Academic and Research Institutes: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        CRO Laboratories: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        North America: Liver Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 24.        North America: Liver Cancer Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 25.        US: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.        Canada: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        Mexico: Liver Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)